Modulating tumor-associated macrophages through CSF1R inhibition: a potential therapeutic strategy for HNSCC

被引：0

作者：

Kaiting Chen ^{[1
]}

Xiaochen Li ^{[2
]}

Shuyi Dong ^{[1
]}

Yu Guo ^{[2
]}

Ziyin Luo ^{[2
]}

Shi-Min Zhuang ^{[1
]}

Jie Liu ^{[2
]}

Tianrun Liu ^{[1
]}

Jing Liao ^{[2
]}

Weiping Wen ^{[1
]}

机构：

[1] Sun Yat-Sen University,Department of General Surgery of Otorhinolaryngology Head and Neck, The Sixth Affiliated Hospital

[2] Sun Yat-Sen University,Biomedical Innovation Center, The Sixth Affiliated Hospital

[3] Guangzhou Medical University,GMU

[4] Sun Yat-sen Memorial Hospital,GIBH Joint School of Life Sciences, The Guangdong

[5] Sun Yat-sen University,Hong Kong

[6] The First Affiliated Hospital of Sun Yat-Sen University,Macau, Joint Laboratory for Cell Fate Regulation and Diseases

来源：

Journal of Translational Medicine | / 23卷 / 1期

关键词：

HNSCC; TAMs; CSF1R inhibitors; Cisplatin; Combination therapy;

D O I：

10.1186/s12967-024-06036-3

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] A novel cancer therapeutic strategy: inducing cytotoxic functions in tumor-associated macrophages
Barham, Whitney
Tikhomirov, Oleg
Ortega, Ryan
Saskowski, Jeannette
Thompson, Courtney S.
Wilson, Andrew
Blackwell, Timothy
Mirafzali, Zahra
Khabele, Dineo
Giorgio, Todd
Yull, Fiona E.
CANCER RESEARCH, 2015, 75
[32] Metabolic reprogramming of hypoxic tumor-associated macrophages through CSF-1R targeting favors treatment efficiency in colorectal cancers
Gharzeddine, Khaldoun
Prieto, Cristina Gonzalez
Malier, Marie
Hennot, Clara
Grespan, Renata
Yamaryo-Botte, Yoshiki
Botte, Cyrille Y.
Thomas, Fabienne
Laverriere, Marie-Helene
Girard, Edouard
Roth, Gael
Millet, Arnaud
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (09)
[33] CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells
Smirnova, Tatiana
Spertini, Caroline
Spertini, Olivier
CANCERS, 2021, 13 (21)
[34] Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Komohara, Yoshihiro
Fujiwara, Yukio
Ohnishi, Koji
Takeya, Motohiro
ADVANCED DRUG DELIVERY REVIEWS, 2016, 99 : 180 - 185
[35] The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target
Gambardella, V
Castillo, J.
Tarazona, N.
Gimeno-Valiente, F.
Martinez-Ciarpaglini, C.
Cabeza-Segura, M.
Rosello, S.
Roda, D.
Huerta, M.
Cervantes, A.
Fleitas, T.
CANCER TREATMENT REVIEWS, 2020, 86
[36] CSF1R Expression of Hodgkin Reed Sternberg Cells Is Associated with the Number of Macrophages in the Tumor Microenvironment and Is Correlated with Treatment Outcome
Steidl, Christian
Diepstra, Arjan
Lee, Tang
Farinha, Pedro
Telenius, Adele
Boyle, Merrill
Shah, Sohrab P.
Barclay, Lorena
Van Den Berg, Anke
Savage, Kerry J.
Connors, Joseph M.
Gascoyne, Randy D.
BLOOD, 2011, 118 (21) : 197 - 197
[37] Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models.
Li, Yanxia
Mathew, Sneha
Wu, Lan
Wang, Ying
Persaud, Kris
Burtrum, Douglas
Balderes, Paul
Surguladze, David
Haurum, John
Ludwig, Dale
Doody, Jacqueline
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
[38] Colony Stimulating Factor 1 Receptor (CSF1R) As a Potential Novel Therapeutic Target in CLL
Sweeney, Tyler
Spurgeon, Stephen E.
Tyner, Jeffrey W.
Agarwal, Anupriya
Ho, Hibery
Traer, Elie
Lee, Patrice
Chantry, David
Druker, Brian J.
Loriaux, Marc
BLOOD, 2015, 126 (23)
[39] Friend or foe: Reevaluating the therapeutic potential of monocytes and tumor-associated macrophages in ovarian cancer
Yeku, Oladapo
CANCER RESEARCH, 2024, 84 (05)
[40] Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors
Cassetta, Luca
Kitamura, Takanori
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2018, 6

← 1 2 3 4 5 →